Press release
Anemia in the Elderly Market: Industry Overview, Emerging Trends, and Key Player Analysis
Anemia In Elderly Market
Projected Market Value and Growth Path of the Anemia in Elderly Market
The anemia in elderly market is poised for substantial expansion in the coming years. By 2030, its value is anticipated to reach $4.59 billion, advancing at a compound annual growth rate (CAGR) of 8.9%. This expected growth is largely fueled by increasing demand for personalized anemia therapies, wider acceptance of long-acting injectable treatments, a heightened focus on healthcare for older adults, growth in outpatient anemia management, and better diagnostic screening tailored to elderly care. Additionally, key trends driving the sector include greater use of combination therapies, rising preference for injectable iron formulations, an emphasis on early anemia detection in the elderly, expansion of home-based treatment options, and stronger attention to managing anemia linked to chronic diseases.
Download a free sample of the anemia in elderly market report:
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Market Leaders in the Anemia in Elderly Sector
Several prominent companies are influencing the anemia in elderly market, including Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, and MegaPro Biomedical Co Ltd.
A significant recent development occurred in February 2025 when AstraZeneca, headquartered in the UK, acquired FibroGen, Inc. for $160 million. This strategic acquisition aims to bolster AstraZeneca's position in the Chinese anemia therapeutics market by obtaining full rights to roxadustat, including its manufacturing, development, and commercialization. FibroGen is a US-based biopharmaceutical firm specializing in innovative therapies at the intersection of cancer biology and anemia.
Current Trends Influencing the Anemia in Elderly Market
Innovations in product development are shaping the competitive landscape, especially through the introduction of advanced medical devices. For instance, companies are advancing atherectomy device technologies to treat peripheral artery disease, which often affects elderly patients.
In October 2023, Cardio Flow, a US medical device manufacturer, launched FreedomFlow, an orbital atherectomy peripheral platform. This device utilizes a unique catheter design that employs angular momentum physics and features spiral geometry with five diamond-coated spheres. These spheres maintain continuous contact with the vessel wall during navigation, improving the removal of plaque blockages in leg arteries and enhancing treatment efficacy.
Exploring the future potential of healthcare for the elderly reveals promising developments in anemia management. With an aging population and advancing medical technologies, the anemia in elderly market is set to experience significant growth, driven by innovative treatments and enhanced care approaches. Let's delve into the market size, key players, current trends, and segment classifications shaping this industry.
Projected Market Value and Growth Path of the Anemia in Elderly Market
The anemia in elderly market is poised for substantial expansion in the coming years. By 2030, its value is anticipated to reach $4.59 billion, advancing at a compound annual growth rate (CAGR) of 8.9%. This expected growth is largely fueled by increasing demand for personalized anemia therapies, wider acceptance of long-acting injectable treatments, a heightened focus on healthcare for older adults, growth in outpatient anemia management, and better diagnostic screening tailored to elderly care. Additionally, key trends driving the sector include greater use of combination therapies, rising preference for injectable iron formulations, an emphasis on early anemia detection in the elderly, expansion of home-based treatment options, and stronger attention to managing anemia linked to chronic diseases.
Download a free sample of the anemia in elderly market report:
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Market Leaders in the Anemia in Elderly Sector
Several prominent companies are influencing the anemia in elderly market, including Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, and MegaPro Biomedical Co Ltd.
A significant recent development occurred in February 2025 when AstraZeneca, headquartered in the UK, acquired FibroGen, Inc. for $160 million. This strategic acquisition aims to bolster AstraZeneca's position in the Chinese anemia therapeutics market by obtaining full rights to roxadustat, including its manufacturing, development, and commercialization. FibroGen is a US-based biopharmaceutical firm specializing in innovative therapies at the intersection of cancer biology and anemia.
Current Trends Influencing the Anemia in Elderly Market
Innovations in product development are shaping the competitive landscape, especially through the introduction of advanced medical devices. For instance, companies are advancing atherectomy device technologies to treat peripheral artery disease, which often affects elderly patients.
In October 2023, Cardio Flow, a US medical device manufacturer, launched FreedomFlow, an orbital atherectomy peripheral platform. This device utilizes a unique catheter design that employs angular momentum physics and features spiral geometry with five diamond-coated spheres. These spheres maintain continuous contact with the vessel wall during navigation, improving the removal of plaque blockages in leg arteries and enhancing treatment efficacy.
Comprehensive Segmentation of the Anemia in Elderly Market
The anemia in elderly market is segmented across several categories to cover the diverse range of products and treatment methods:
1) By Product Type: Tablets and Injectables
2) By Treatment Type: Iron Supplements, Erythropoietin or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, and Folic Acid Supplements
3) By Route of Administration: Oral and Parenteral
4) By End User: Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy
Further breakdown includes:
1) Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, and Erythropoiesis-Stimulating Agents (ESAs) Tablets
2) Injectables: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, and Folic Acid Injections
This detailed segmentation allows for precise targeting and evaluation of market needs across different treatment forms and distribution channels.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anemia in the Elderly Market: Industry Overview, Emerging Trends, and Key Player Analysis here
News-ID: 4459438 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Analysis of the Academic Medical Cen …
The academic medical center sector is on a trajectory of remarkable growth, driven by advancements in medical research, education, and patient care integration. As these centers evolve, they are becoming pivotal hubs combining clinical expertise, cutting-edge research, and specialized training. This overview delves into the market's projected expansion, leading organizations, emerging trends, and detailed segmentation to provide a clear picture of the industry's future.
Projected Growth and Market Size of the…
Emerging Sub-Segments Transforming the Antibody Validation Market Landscape
The antibody validation industry is poised for remarkable expansion as demand intensifies across varied sectors such as clinical research and precision diagnostics. This market's rapid development is driven by a need for reproducible and reliable antibody data, alongside technological progress that supports more efficient validation processes. Let's explore the current market size, influential companies, emerging trends, and key segments shaping the future of antibody validation.
Projected Market Value and Growth Drivers…
Key Companies Leading Innovation and Growth in the 3-in-1 Oral Cone Beam Compute …
The 3-in-1 oral cone beam computed tomography (CBCT) market is on a promising growth path, driven by technological advancements and increasing demand for comprehensive dental imaging solutions. This report explores the market's future size, key players, influential trends, and detailed segment breakdowns, offering a clear picture of what lies ahead for this specialized medical imaging sector.
Projected Expansion and Market Size for the 3-in-1 Oral Cone Beam Computed Tomography CBCT Market…
Competitive Landscape: Key Market Leaders and New Entrants in the Antibiotic Res …
The antibiotic resistance market is becoming an increasingly crucial area within healthcare due to the rising challenge of drug-resistant infections worldwide. This market is set to experience significant growth as efforts intensify toward developing new treatments and improving diagnostic tools to combat resistant pathogens effectively. Below is an overview of the market's forecast, key players, emerging trends, and segmentation.
Forecasted Market Size and Growth Trajectory for Antibiotic Resistance
The antibiotic resistance…
More Releases for Anemia
Chemotherapy-Induced Anemia Market Forecast by Type Mild Moderate Severe and Lif …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)), By Region, Trends, Industry Competition…
Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period?
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM.
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,…
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435
This latest report researches the industry structure,…
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022
Global Anemia Drugs Market - Segments
Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;…
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,…
